
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 73233
[patent_doc_number] => 07749493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Chimeric adenoviruses'
[patent_app_type] => utility
[patent_app_number] => 11/207626
[patent_app_country] => US
[patent_app_date] => 2005-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 10
[patent_no_of_words] => 21424
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749493.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207626 | Chimeric adenoviruses | Aug 17, 2005 | Issued |
Array
(
[id] => 8527663
[patent_doc_number] => 08304233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-06
[patent_title] => 'Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same'
[patent_app_type] => utility
[patent_app_number] => 11/198885
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 29
[patent_no_of_words] => 98577
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11198885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198885 | Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same | Aug 3, 2005 | Issued |
Array
(
[id] => 9239034
[patent_doc_number] => 08603824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-10
[patent_title] => 'Process for improved protein expression by strain engineering'
[patent_app_type] => utility
[patent_app_number] => 11/189375
[patent_app_country] => US
[patent_app_date] => 2005-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 36952
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 733
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11189375
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/189375 | Process for improved protein expression by strain engineering | Jul 25, 2005 | Issued |
Array
(
[id] => 5767433
[patent_doc_number] => 20060019237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'In vitro wound healing assay and device'
[patent_app_type] => utility
[patent_app_number] => 11/185434
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9027
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11185434
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/185434 | In vitro wound healing assay and device | Jul 18, 2005 | Abandoned |
Array
(
[id] => 576125
[patent_doc_number] => 07459546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-02
[patent_title] => 'Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase regulatory sequences for gene expression in oleaginous yeast'
[patent_app_type] => utility
[patent_app_number] => 11/183664
[patent_app_country] => US
[patent_app_date] => 2005-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 27828
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/459/07459546.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183664
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183664 | Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase regulatory sequences for gene expression in oleaginous yeast | Jul 17, 2005 | Issued |
Array
(
[id] => 4824866
[patent_doc_number] => 20080124308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins'
[patent_app_type] => utility
[patent_app_number] => 11/632302
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11862
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632302
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632302 | Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins | Jul 13, 2005 | Abandoned |
Array
(
[id] => 5767604
[patent_doc_number] => 20060019292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same'
[patent_app_type] => utility
[patent_app_number] => 11/181148
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19453
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20060019292.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181148
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181148 | Sequence specific recombinase-based methods for producing intron containing vectors and compositions for use in practicing the same | Jul 12, 2005 | Abandoned |
Array
(
[id] => 5141306
[patent_doc_number] => 20070003522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Methods and compositions for improved retroviral gene and drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/175401
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27843
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20070003522.pdf
[firstpage_image] =>[orig_patent_app_number] => 11175401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/175401 | Methods and compositions for improved retroviral gene and drug delivery | Jul 6, 2005 | Abandoned |
Array
(
[id] => 5894913
[patent_doc_number] => 20060003452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Vector packaging cell line'
[patent_app_type] => utility
[patent_app_number] => 11/172147
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003452.pdf
[firstpage_image] =>[orig_patent_app_number] => 11172147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/172147 | Vector packaging cell line | Jun 29, 2005 | Abandoned |
Array
(
[id] => 5826914
[patent_doc_number] => 20060062772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Polypeptide delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/166340
[patent_app_country] => US
[patent_app_date] => 2005-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4713
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11166340
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/166340 | Polypeptide delivery system | Jun 26, 2005 | Abandoned |
Array
(
[id] => 7772955
[patent_doc_number] => 08119119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Non-integrative and non-replicative lentivirus, preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/628534
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9353
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11628534
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/628534 | Non-integrative and non-replicative lentivirus, preparation and uses thereof | Jun 23, 2005 | Issued |
Array
(
[id] => 5894357
[patent_doc_number] => 20060002896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Method of generating recombinant MVA'
[patent_app_type] => utility
[patent_app_number] => 11/149793
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7904
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002896.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149793 | Method of generating recombinant MVA | Jun 9, 2005 | Abandoned |
Array
(
[id] => 73232
[patent_doc_number] => 07749492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'AAV vectors and methods'
[patent_app_type] => utility
[patent_app_number] => 11/145035
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13367
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/749/07749492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11145035
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/145035 | AAV vectors and methods | Jun 2, 2005 | Issued |
Array
(
[id] => 6966003
[patent_doc_number] => 20050232900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Serotype of adenovirus and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/140418
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 41134
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11140418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/140418 | Serotype of adenovirus and uses thereof | May 26, 2005 | Abandoned |
Array
(
[id] => 5343257
[patent_doc_number] => 20090181907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter'
[patent_app_type] => utility
[patent_app_number] => 11/569625
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8124
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569625
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569625 | Drug comprising as the active ingredient proliferative vector containing survivin promoter | May 22, 2005 | Issued |
Array
(
[id] => 7020055
[patent_doc_number] => 20050222074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Modulators of bone homeostasis identified in a high-throughput screen'
[patent_app_type] => utility
[patent_app_number] => 11/133849
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 32670
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133849
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133849 | Modulators of bone homeostasis identified in a high-throughput screen | May 19, 2005 | Abandoned |
Array
(
[id] => 4486423
[patent_doc_number] => 07884085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/127360
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3721
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127360
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127360 | Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes | May 11, 2005 | Issued |
Array
(
[id] => 352790
[patent_doc_number] => 07491812
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-02-17
[patent_title] => 'Copper-inducible promoter system'
[patent_app_type] => utility
[patent_app_number] => 11/120009
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1481
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491812.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120009
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120009 | Copper-inducible promoter system | May 1, 2005 | Issued |
Array
(
[id] => 4771926
[patent_doc_number] => 20080057584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Intervention In The Energy Metabolism Of Eukaryote Cells For The Purposes Of Selection And Increased Expression'
[patent_app_type] => utility
[patent_app_number] => 11/578567
[patent_app_country] => US
[patent_app_date] => 2005-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8425
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578567 | Intervention In The Energy Metabolism Of Eukaryote Cells For The Purposes Of Selection And Increased Expression | Apr 14, 2005 | Abandoned |
Array
(
[id] => 4563447
[patent_doc_number] => 07846687
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Cytomegalovirus Intron A fragments'
[patent_app_type] => utility
[patent_app_number] => 11/103805
[patent_app_country] => US
[patent_app_date] => 2005-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 13366
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846687.pdf
[firstpage_image] =>[orig_patent_app_number] => 11103805
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/103805 | Cytomegalovirus Intron A fragments | Apr 10, 2005 | Issued |